Trial Profile
A post marketing study of NUZYRA in CABP and pediatrics
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2018
Price :
$35
*
At a glance
- Drugs Omadacycline (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Paratek Pharmaceuticals
- 09 Oct 2018 New trial record